12.00- 12.10  

prof. MACIEJ MAŁECKI 

Jagiellonian University, Kraków, Poland
 
prof. ARTUR JURCZYSZYN

Jagiellonian University, Kraków, Poland

opening the conference

Chairmen of the Session nr I 

prof. Wiesław W.Jędrzejczak, 
prof.Aleksander Skotnicki
prof. Ewa Lech-Marańda

12.10 - 12.30

prof. MEERA MOHAN

Medical College of Wisconsin, USA 

12.30-12.40

 discussion

12.40 - 13.00

prof. LALIT KUMAR 

All Insia Institute od Medical Sciences, India

 “How I treat plasma cell dyscrasias in India in 2025?”

13.00-13.10

discussion

13.10 - 13.30

prof. RAFAEL FONSECA

Mayo Clinic, USA

“Impact of disease progression, line of therapy and response on health-related quality of life in multiple myeloma”  

13.30-13.40

discussion

13.40 - 14.00

prof. ERINI KATODRITOU

Theagenio Cancer Hospital, Thessaloniki, Greece

14.00-14.15

discussion

14.15 - 15.00

COFFE BREAK 

Chairmen of the Session nr II

prof.Tomasz Sacha
prof. Bogusław Machaliński,
prof. Krzysztof Giannopoulos  

15.00 -15.20

prof. MICHAEL O'DWYER

University of Galway, Ireland

“Immunotherapy in high risk multiple myeloma”

15.20-15.30

discussion

15.30 -15.50

prof. CHOR SANG CHIM

University of Hong Kong, Hong Kong

“High-risk myeloma: a fast moving target & an unmet medical need”

15.50-16.00

discussion

16.00 – 16.20 

prof. HERMANN EINSELE

University ospital of Wuerzburg, Germany

 “Optimal use of T-cell engaging bispecific antibodies in multiple myeloma” 

16.20-16.30

discussion

16.30 - 16.50

 prof. ARTUR JURCZYSZYN

Jagiellonian University, Kraków, Poland  

“Polish algorithm for therapy of multiple myeloma in 2025”